Pancrelipase Recruiting Phase 4 Trials for Cystic Fibrosis (CF) Treatment

RecruitingTreatment4 IdentifierTitleDrugs
NCT03924947A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis